# Trial of Concurrent Chemoradiotherapy for Locally Advanced Esophageal Cancer

> **NCT02762474** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Tianjin Medical University Cancer Institute and Hospital** · enrollment: 30 (estimated)

## Conditions studied

- Esophageal Cancer

## Interventions

- **DRUG:** nab-paclitaxel group

## Key facts

- **NCT ID:** NCT02762474
- **Lead sponsor:** Tianjin Medical University Cancer Institute and Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-07
- **Primary completion:** 2017-11
- **Final completion:** 2017-12
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2017-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02762474

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02762474, "Trial of Concurrent Chemoradiotherapy for Locally Advanced Esophageal Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02762474. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*